{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:06:35Z","timestamp":1784070395178,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xkme.2026.101242","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:13:18Z","timestamp":1767719598000},"page":"101242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy"],"prefix":"10.1016","volume":"8","author":[{"given":"Abdallah S.","family":"Geara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly B.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101242_bib1","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.3390\/jcm10194501","article-title":"Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment","volume":"10","author":"Knoppova","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.xkme.2026.101242_bib2","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2023.08.007","article-title":"The treatment of primary IgA nephropathy: change, change, change","volume":"83","author":"Caster","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2026.101242_bib4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/ndt\/gfaf059","article-title":"Active glomerular inflammation versus chronicity and fibrosis: the role of targeted therapies in IgA nephropathy","volume":"40","author":"Radhakrishnan","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101242_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ekir.2017.08.008","article-title":"Life expectancy for patients from the southeastern United States with IgA nephropathy","volume":"3","author":"Hastings","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2026.101242_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.2018101017","article-title":"Mortality in IgA nephropathy: a nationwide population-based cohort study","volume":"30","author":"Jarrick","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.36469\/jheor.2021.26129","article-title":"A systematic literature review of the epidemiology, health-related quality of life impact, and economic burden of immunoglobulin A nephropathy","volume":"8","author":"Kwon","year":"2021","journal-title":"J Health Econ Outcomes Res"},{"issue":"suppl 2","key":"10.1016\/j.xkme.2026.101242_bib9","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ckj\/sfad199","article-title":"Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis","volume":"16","author":"Lee","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.xkme.2026.101242_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA nephropathy: a global perspective","volume":"38","author":"Schena","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am J Med Sci"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2026.101242_bib12","article-title":"The diagnostic journey of patients with immunoglobulin A nephropathy: data analysis of a real-world survey","volume":"38","author":"Kroes","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101242_bib13","article-title":"WCN23-0625: The patient journey for immunoglobulin A nephropathy: diagnostic delay and change in kidney function from first clinical sign","volume":"8","author":"Perkins","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"suppl","key":"10.1016\/j.xkme.2026.101242_bib14","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1681\/ASN.20203110S1834c","article-title":"Patient journey, perceptions, and burden associated with immunoglobulin A nephropathy (IgAN): a qualitative study","volume":"31","author":"Zaour","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib16","author":"Feldman"},{"key":"10.1016\/j.xkme.2026.101242_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.xkme.2026.101242_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/ijpvm.IJPVM_557_18","article-title":"Simplified algorithm for evaluation of proteinuria in clinical practice: how should a clinician approach?","volume":"10","author":"Mazaheri","year":"2019","journal-title":"Int J Prev Med"},{"issue":"4S","key":"10.1016\/j.xkme.2026.101242_bib19","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2025.04.004","article-title":"KDIGO 2025 Clinical Practice Guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV)","volume":"108","author":"Rovin","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2013.512","article-title":"Utility of renal biopsy in the clinical management of renal disease","volume":"85","author":"Dhaun","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib22","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.3390\/jcm12196424","article-title":"Renal biopsy for diagnosis in kidney disease: indication, technique, and safety","volume":"12","author":"Schnuelle","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xkme.2026.101242_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0039-1688422","article-title":"Complications of percutaneous renal biopsy","volume":"36","author":"Bakdash","year":"2019","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.xkme.2026.101242_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ndt\/gfv044","article-title":"Con: kidney biopsy: an irreplaceable tool for patient management in nephrology","volume":"30","author":"Glassock","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101242_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310358","article-title":"\u2018Was my kidney biopsy worth it?\u2019-A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy","volume":"19","author":"Toal","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2026.101242_bib26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/jcm13040947","article-title":"An update on current therapeutic options in IgA nephropathy","volume":"13","author":"Lim","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.xkme.2026.101242_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","article-title":"A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy","volume":"100","author":"Wheeler","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(23)00322-4","article-title":"Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial","volume":"12","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.xkme.2026.101242_bib29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0140-6736(23)00569-X","article-title":"Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial","volume":"401","author":"Heerspink","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xkme.2026.101242_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa2409415","article-title":"Atrasentan in patients with IgA nephropathy","volume":"392","author":"Heerspink","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101242_bib31","series-title":"VANRAFIA\u2122 (atrasentan) tablets","year":"2025"},{"key":"10.1016\/j.xkme.2026.101242_bib33","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2022.5368","article-title":"Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"327","author":"Lv","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.xkme.2026.101242_bib34","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00467-023-06259-4","article-title":"Childhood-onset IgA nephropathy: is long-term recovery possible?","volume":"39","author":"Antonucci","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib35","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.ekir.2023.09.034","article-title":"Clinical practice patterns in IgA nephropathy: a global questionnaire-based survey","volume":"8","author":"Bansal","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2026.101242_bib36","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101242_bib37","series-title":"TARPEYO\u00ae (budesonide) delayed release capsules","year":"2024"},{"key":"10.1016\/j.xkme.2026.101242_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221325","article-title":"Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study","volume":"14","author":"Sperati","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2026.101242_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2010.08.027","article-title":"Quality of patient-physician discussions about CKD in primary care: a cross-sectional study","volume":"57","author":"Greer","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2026.101242_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ackd.2010.03.002","article-title":"Awareness of chronic kidney disease among patients and providers","volume":"17","author":"Plantinga","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.xkme.2026.101242_bib42","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1475-6773.2011.01354.x","article-title":"Patient-physician role relationships and patient activation among individuals with chronic illness","volume":"47","author":"Alexander","year":"2012","journal-title":"Health Serv Res"},{"key":"10.1016\/j.xkme.2026.101242_bib43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ekir.2021.02.030","article-title":"Identifying information needs of patients with IgA nephropathy using an innovative social media-stepped analytical approach","volume":"6","author":"Vasilica","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2026.101242_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ndt\/gfh709","article-title":"Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement","volume":"20","author":"Wauters","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101242_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000444026","article-title":"Renal biopsy in 2015\u2014from epidemiology to evidence-based indications","volume":"43","author":"Fiorentino","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib46","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.kint.2021.10.007","article-title":"Addressing the nephrology workforce shortage via a novel undergraduate pipeline program: the Kidney Disease Screening and Awareness Program (KDSAP) at 10 years","volume":"100","author":"Jiang","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101242_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1525-139X.2011.00933.x","article-title":"Implications of a nephrology workforce shortage for dialysis patient care","volume":"24","author":"Mehrotra","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.xkme.2026.101242_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.56412","article-title":"Cost-effectiveness of school urinary screening for early detection of IgA nephropathy in Japan","volume":"7","author":"Honda","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xkme.2026.101242_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1436923","article-title":"Contemporary review of IgA nephropathy","volume":"15","author":"Filippone","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2026.101242_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urolonc.2012.07.001","article-title":"What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up","volume":"32","author":"Buteau","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.xkme.2026.101242_bib51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/AOG.0000000000003355","article-title":"Referral patterns for the evaluation of asymptomatic microscopic hematuria in women in a single health care system: room for improvement","volume":"134","author":"Handler","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xkme.2026.101242_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.ajkd.2006.04.073","article-title":"Identification and referral of patients with progressive CKD: a national study","volume":"48","author":"Boulware","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2026.101242_bib53","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archinte.164.16.1788","article-title":"Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program","volume":"164","author":"Akbari","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.xkme.2026.101242_bib54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.13101019","article-title":"Identifying outcomes important to patients with glomerular disease and their caregivers","volume":"15","author":"Carter","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib55","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.pec.2015.06.022","article-title":"Shared decision making: concepts, evidence, and practice","volume":"98","author":"Stiggelbout","year":"2015","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.xkme.2026.101242_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11136-024-03813-x","article-title":"The humanistic burden of immunoglobulin A nephropathy on patients and care-partners in the United States","volume":"34","author":"Szklarzewicz","year":"2025","journal-title":"Qual Life Res"},{"key":"10.1016\/j.xkme.2026.101242_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.34067\/KID.0000000613","article-title":"Clinical and humanistic burden of IgA nephropathy in adult patients: a global real-world survey","volume":"6","author":"Tang","year":"2024","journal-title":"Kidney360"},{"key":"10.1016\/j.xkme.2026.101242_bib58","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/j.ekir.2023.02.584","article-title":"WCN23-0369 symptom burden of patients with IgA nephropathy in a real world setting across geographies","volume":"8","author":"Lafayette","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2026.101242_bib59","article-title":"Patient insights for immunoglobulin A nephropathy (IgAN) using social media listening","volume":"22","author":"Tyagi","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.xkme.2026.101242_bib60","doi-asserted-by":"crossref","first-page":"FR","DOI":"10.1681\/ASN.20241dfd2nyr","article-title":"Conceptual model of the patient experience of IgAN: a qualitative literature review and model update","volume":"35","author":"Knight","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib61","doi-asserted-by":"crossref","first-page":"FR","DOI":"10.1681\/ASN.2024a8d7tdzd","article-title":"Disease burden of IgA nephropathy (IgAN): a linguistic analysis of global social media conversations over time: a comparison of results, 2019-2023","volume":"35","author":"Oberdhan","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519898008","article-title":"Effect of physical activity on depression symptoms in patients with IgA nephropathy","volume":"48","author":"Zhao","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.xkme.2026.101242_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vhri.2021.07.011","article-title":"Cost analysis of screening for IgA nephropathy using novel biomarkers","volume":"29","author":"Ishida","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.xkme.2026.101242_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100693","article-title":"Impact of proteinuria and kidney function decline on health care costs and resource utilization in adults with IgA nephropathy in the United States: a retrospective analysis","volume":"5","author":"Lerma","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.xkme.2026.101242_bib65","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00467-023-06250-z","article-title":"Ongoing impacts of childhood-onset glomerular diseases during young adulthood","volume":"39","author":"Furuie","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2026.101242_bib66","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s40620-021-00979-2","article-title":"Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study","volume":"34","author":"Jarrick","year":"2021","journal-title":"J Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2026.101242_bib67","first-page":"2740","article-title":"Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease","volume":"39","author":"Tummala","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101242_bib69","series-title":"FARXIGA\u00ae (dapagliflozin) tablets","year":"2024"},{"key":"10.1016\/j.xkme.2026.101242_bib68","series-title":"Boehringer Ingelheim Pharmaceuticals Inc. JARDIANCE\u00ae (empagliflozin tablets)","year":"2023"},{"key":"10.1016\/j.xkme.2026.101242_bib70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12882-019-1560-2","article-title":"Clinical practice guideline on pregnancy and renal disease","volume":"20","author":"Wiles","year":"2019","journal-title":"BMC Nephrol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:20:56Z","timestamp":1784067656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2590059526000038"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101242","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101242"}}